Audrey Kunin - 22 Nov 2021 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Chief Product Officer
Signature
/s/ Audrey Kunin
Issuer symbol
NBY
Transactions as of
22 Nov 2021
Net transactions value
+$41,868
Form type
4
Filing time
24 Nov 2021, 15:46:52 UTC
Previous filing
17 Nov 2021
Next filing
02 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Purchase $11,500 +25,000 $0.4600 25,000 22 Nov 2021 see footnote F2
transaction NBY Common Stock Purchase $30,368 +66,133 +265% $0.4592 91,133 23 Nov 2021 see footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.4545 to $0.4610. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.